Umbrella_KeckMedicine
umbrella-logo
Keck Medicine of USC is the University of Southern California’s medical enterprise, one of only two university-owned academic medical centers in the Los Angeles area.

News

USC Stem Cell researcher targets ‘seeds’ of breast cancer metastasis

For breast cancer patients, the era of personalized medicine may be just around the corner, thanks to recent advances by USC Stem Cell researcher Min Yu, MD, PhD, and scientists at Massachusetts General Hospital and Harvard Medical School. In a July 10 study in Science, Yu and her colleagues report how they isolated breast cancer ...   Read More »

USC surgeons perform novel robotic-assisted prostate cancer operation

Surgeons at the Keck Medical Center of USC became the first in California to use the latest minimally invasive surgical system for prostate cancer when they performed a robotic-assisted procedure in July. The surgery further cements the Los Angeles-based university hospitals’ position as a global center of excellence for robotic surgery. The procedure used the ...   Read More »

USC surgeons perform novel robotic-assisted prostate cancer operation

Surgeons at the Keck Medical Center of USC became the first in California to use the latest minimally invasive surgical system for prostate cancer when they performed a robotic-assisted procedure in July. The surgery further cements the Los Angeles-based university hospitals’ position as a global center of excellence for robotic surgery. The procedure used the ...   Read More »

Keck Medical Center of USC physician leads new study on genomics of young lung cancer

Barbara Gitlitz, MD, associate professor of medicine at the Keck School of Medicine of USC and members of the USC Norris Comprehensive Cancer Center, is leading a new clinical study to understand why lung cancer occurs in adults under 40 who are athletic, were never smokers and do not exhibit any of the known lung ...   Read More »

Keck Medicine of USC researchers discover dual purpose of cancer drug in regulating expression of genes

Keck Medicine of USC scientists have discovered new clues about a drug instrumental in treating a certain blood cancer that may provide important targets for researchers searching for cures. The team investigated whether demethylation of gene bodies induced by the drug 5-Aza-CdR (decitabine), which is used to treat pre-leukemia, could alter gene expression and possibly ...   Read More »